About 27 million Americans suffer from osteoarthritis. In fact, it is the most common joint disorder in the United States. While there are varying degrees of severity, this condition is a leading cause of work disability, activity limitation, and increased fall risk. Unfortunately, there is no cure. Traditional treatment largely consists of medication and surgical options. However, we have seen excellent results from adipose derived supportive medicinal signaling cell transplant in osteoarthritis treatment.

In our practice, one of the most common complaints we see is knee pain. Whether it’s due to injury or degenerative conditions like osteoarthritis, the result is the same – pain, inflammation, and loss of mobility. Pharmaceutical treatment, while common, is not a silver bullet.

Knee pain is one of the leading complaints we see in our office. In fact, studies show that up to 25% of the population suffers from knee pain at some point in their lives. In many cases, the severity is such that knee surgery and/or replacement becomes the only option. But, for people who haven’t quite reached that point, are too young to receive a knee replacement, have co-morbid medical conditions, or simply want to avoid joint surgery, there is an alternative.  Adipose cell derived knee injections have been shown to reduce pain and improve mobility.  We see many positive outcomes at Piedmont PMR from this treatment. How can adipose derived support and medicinal signaling cell therapy improve your knee pain?